AgingResearch.News
Trials

Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial

By Xin Zhang, Wen Li, Zhongqing Sun, Show 11 more authorsWen Jiang
Interventions
Paper

The paper

Xin Zhang, Wen Li, Zhongqing Sun, Show 11 more authorsWen Jiang

Trials, 9 Oct 2026

doi.org/10.1186/s13063-026-10009-wPubMed 42855713

Related